Literature DB >> 3538905

Carrier-mediated reabsorption of small peptides in renal proximal tubule.

V Ganapathy, F H Leibach.   

Abstract

Recent studies with a variety of tissue preparations in the kidney have demonstrated that proximal tubular cells possess specific transport systems for di- and tripeptides. In contrast to the well-known amino acid and glucose transport systems, active transport of peptides in these cells is energized by an H+ gradient rather than an Na+ gradient. Like amino acid-Na+ and glucose-Na+ cotransport systems, peptide-H+ cotransport is electrogenic and hence a membrane potential also contributes to the uphill transport of peptides in these cells. Di- and tripeptides that are filtered at the glomerulus, as well as those that are produced in the tubular lumen from larger polypeptides by the action of brush-border peptidases, serve as substrates for the renal peptide transport system under physiological conditions. The H+ gradient that is necessary to drive renal peptide transport is generated in vivo by concerted action of the basolateral Na+-K+-ATPase and the brush-border Na+-H+ exchanger. The peptidases and the peptide transport system in the renal brush-border membrane play a significant role in the reabsorption of peptide-bound amino acids as well as in the regulation of plasma levels of small peptides.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3538905     DOI: 10.1152/ajprenal.1986.251.6.F945

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

Review 1.  Pharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins.

Authors:  Iftekhar Mahmood; Martin D Green
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  The use of peptones as medium additives for the production of a recombinant therapeutic protein in high density perfusion cultures of mammalian cells.

Authors:  R Heidemann; C Zhang; H Qi; J Larrick Rule; C Rozales; S Park; S Chuppa; M Ray; J Michaels; K Konstantinov; D Naveh
Journal:  Cytotechnology       Date:  2000-02       Impact factor: 2.058

3.  Distribution and properties of the glycylsarcosine-transport system in rabbit renal proximal tubule. Studies with isolated brush-border-membrane vesicles.

Authors:  Y Miyamoto; J L Coone; V Ganapathy; F H Leibach
Journal:  Biochem J       Date:  1988-01-01       Impact factor: 3.857

Review 4.  Epithelial transport in inflammatory bowel diseases.

Authors:  Fayez K Ghishan; Pawel R Kiela
Journal:  Inflamm Bowel Dis       Date:  2014-06       Impact factor: 5.325

5.  A proton gradient, not a sodium gradient, is the driving force for active transport of lactate in rabbit intestinal brush-border membrane vesicles.

Authors:  C Tiruppathi; D F Balkovetz; V Ganapathy; Y Miyamoto; F H Leibach
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

Review 6.  Function, Regulation, and Pathophysiological Relevance of the POT Superfamily, Specifically PepT1 in Inflammatory Bowel Disease.

Authors:  Emilie Viennois; Adani Pujada; Jane Zen; Didier Merlin
Journal:  Compr Physiol       Date:  2018-03-25       Impact factor: 9.090

7.  Evidence for tripeptide/H+ co-transport in rabbit renal brush-border membrane vesicles.

Authors:  C Tiruppathi; P Kulanthaivel; V Ganapathy; F H Leibach
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

Review 8.  Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution.

Authors:  Thomas Gerloff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-04       Impact factor: 3.000

9.  Characterization of peptide fluxes into human erythrocytes. A proton-n.m.r. study.

Authors:  J E Odoom; I D Campbell; J C Ellory; G F King
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

Review 10.  Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications.

Authors:  David E Smith; Benjamin Clémençon; Matthias A Hediger
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.